Tech Company Financing Transactions
Chiasma Funding Round
Chiasma, based in Waltham, secured $3 million in investment from private investors.
Transaction Overview
Company Name
Announced On
1/6/2011
Transaction Type
Debt
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
460 Totten Pond Rd. 530
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Chiasma is focused on improving the lives of patients by developing and ultimately commercializing oral therapies that eliminate the significant limitations and burdens generally associated with therapies that are currently only available as injections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raj Kannan
Chief Medical Officer
William Ludlam
President
Mark Fitzpatrick
VP - Client Services
Asi Haviv
VP - Finance
Drew Enamait
VP - Marketing
Dana Gelbaum
VP - Regulatory Affairs
Shoshie Katz
Browse more venture capital transactions:
Prev: 1/6/2011: EyeGate Pharmaceuticals venture capital transaction
Next: 1/6/2011: Qik venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs